Cargando…
Dissemination and adoption of comparative effectiveness research findings when findings challenge current practices /
Insufficient evidence regarding the effectiveness of medical treatments has been identified as a key source of inefficiency in the U.S. healthcare system. Variation in the use of diagnostic tests and treatments for patient with similar symptoms or conditions has been attributed to clinical uncertain...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , , , |
| Autores Corporativos: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Santa Monica, CA :
RAND,
2011.
|
| Colección: | Technical report (Rand Corporation)
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | JSTOROA_ocn867484194 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140105s2011 cau ob 000 0 eng d | ||
| 040 | |a RSM |b eng |e pn |c RSM |d JSTOR |d OCLCO |d OCLCF |d OCLCQ |d OCLCO |d OCLCA |d YDXCP |d OCLCQ |d TEF |d COO |d OCLCQ |d UAB |d LND |d ERL |d OTZ |d MERER |d VT2 |d IOG |d VFL |d LOA |d UWO |d BUF |d MOZ |d OCLCO |d ICG |d OCLCO |d U3W |d WYU |d NJT |d OCLCO |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 066 | |c (Q | ||
| 019 | |a 863419304 |a 903049934 | ||
| 020 | |a 9780833079367 |q (electronic bk.) | ||
| 020 | |a 0833079360 |q (electronic bk.) | ||
| 027 | |a RAND/TR-924-DHHS | ||
| 029 | 1 | |a AU@ |b 000053008996 | |
| 029 | 1 | |a AU@ |b 000061155391 | |
| 029 | 1 | |a GBVCP |b 1008660671 | |
| 029 | 1 | |a AU@ |b 000066343746 | |
| 035 | |a (OCoLC)867484194 |z (OCoLC)863419304 |z (OCoLC)903049934 | ||
| 050 | 4 | |a R852 |b .S36 2011eb | |
| 072 | 7 | |a MED112000 |2 bisacsh | |
| 072 | 7 | |a MED036000 |2 bisacsh | |
| 072 | 7 | |a MED106000 |2 bisacsh | |
| 082 | 0 | 4 | |a 610.72 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Schneider, Eric C., |c M.D., |e author. | |
| 245 | 1 | 0 | |a Dissemination and adoption of comparative effectiveness research findings when findings challenge current practices / |c Eric C. Schneider [and four others]. |
| 264 | 1 | |a Santa Monica, CA : |b RAND, |c 2011. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Technical report | |
| 500 | |a "RAND Health." | ||
| 500 | |a Document formatted into pages; contains 132 pages. | ||
| 500 | |a Title from title screen (viewed November 28, 2011). | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction and summary of approach -- CATIE case study -- COURAGE case-study report -- SPORT case-study report -- COMPANION case-study report -- CPOE case-study report -- Factors influencing the translation of CER research into new clinical practices: a synthesis of themes from the case studies -- Policy implications of the case-study results. | |
| 520 | |a Insufficient evidence regarding the effectiveness of medical treatments has been identified as a key source of inefficiency in the U.S. healthcare system. Variation in the use of diagnostic tests and treatments for patient with similar symptoms or conditions has been attributed to clinical uncertainty, since the published scientific evidence base does not provide adequate information to determine which treatments are most effective for patients with specific clinical needs. The federal government has made a dramatic investment in comparative effectiveness research (CER), with the expectation that CER will influence clinical practice and improve the efficiency of healthcare delivery. To do this, CER must provide information that supports fundamental changes in healthcare delivery and informs the choice of diagnostic and treatment strategies. This report summarizes findings from a qualitative analysis of the factors that impede the translation of CER into clinical practice and those that facilitate it. A case-study methodology is used to explore the extent to which these factors led to changes in clinical practice following five recent key CER studies. The enabling factors and barriers to translation for each study are discussed, the root causes for the failure of translation common to the studies are synthesized, and policy options that may optimize the impact of future CER--particularly CER funded through the American Recovery and Reinvestment Act of 2009--are proposed. | ||
| 590 | |a JSTOR |b Books at JSTOR Open Access | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 650 | 0 | |a Medicine |x Research |x Evaluation. | |
| 650 | 0 | |a Evidence-based medicine. | |
| 650 | 0 | |a Medical care |x Quality control. | |
| 650 | 2 | |a Clinical Trials as Topic | |
| 650 | 2 | |a Comparative Effectiveness Research | |
| 650 | 2 | |a Delivery of Health Care |x methods | |
| 650 | 2 | |a Evidence-Based Medicine | |
| 650 | 2 | |a Quality Assurance, Health Care | |
| 650 | 2 | |a Evidence-Based Practice | |
| 650 | 6 | |a Médecine |x Recherche |x Évaluation. | |
| 650 | 6 | |a Médecine factuelle. | |
| 650 | 6 | |a Soins médicaux |x Qualité |x Contrôle. | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a Medical care |x Quality control |2 fast | |
| 650 | 7 | |a Evidence-based medicine |2 fast | |
| 650 | 7 | |a Medicine |x Research |x Evaluation |2 fast | |
| 700 | 1 | |a Timbie, Justin W., |e author. | |
| 700 | 1 | |a Fox, D. Steven, |e author. | |
| 700 | 1 | |a Van Busum, Kristin R., |e author. | |
| 700 | 1 | |a Caloyeras, John P., |e author. | |
| 710 | 2 | |a RAND Health. | |
| 710 | 2 | |a Rand Corporation. | |
| 710 | 1 | |a United States. |b Department of Health and Human Services. | |
| 830 | 0 | |a Technical report (Rand Corporation) | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.7249/j.ctt3fh0hb |z Texto completo |
| 880 | |6 520-00/(Q |a Insufficient evidence regarding the effectiveness of medical treatments has been identified as a key source of inefficiency in the U.S. healthcare system. Variation in the use of diagnostic tests and treatments for patient with similar symptoms or conditions has been attributed to clinical uncertainty, since the published scientific evidence base does not provide adequate information to determine which treatments are most effective for patients with specific clinical needs. The federal government has made a dramatic investment in comparative effectiveness research (CER), with the expectation that CER will influence clinical practice and improve the efficiency of healthcare delivery. To do this, CER must provide information that supports fundamental changes in healthcare delivery and informs the choice of diagnostic and treatment strategies. This report summarizes findings from a qualitative analysis of the factors that impede the translation of CER into clinical practice and those that facilitate it. A case-study methodology is used to explore the extent to which these factors led to changes in clinical practice following five recent key CER studies. The enabling factors and barriers to translation for each study are discussed, the root causes for the failure of translation common to the studies are synthesized, and policy options that may optimize the impact of future CERѓ́ʻ⁺ѓє́ѕparticularly CER funded through the American Recovery and Reinvestment Act of 2009ѓ́ʻ⁺ѓє́ѕare proposed. | ||
| 938 | |a YBP Library Services |b YANK |n 11820874 | ||
| 994 | |a 92 |b IZTAP | ||